Development of Self-Assembling Mixed Protein Micelles with Temperature-Modulated Avidities

Elastin‐like polypeptides (ELPs) are polypentapeptides that undergo hydrophobic collapse and aggregation above a specific transition temperature, Tt. ELP diblocks sharing a common “core” block (I60) but varying “outer” blocks (A80, P40) were designed, where Tt,I < Tt,A < Tt,P. The formation of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced healthcare materials 2013-07, Vol.2 (7), p.1045-1055
Hauptverfasser: Soon, Allyson S. C., Smith, Michael H., Herman, Emily S., Lyon, L. Andrew, Barker, Thomas H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Elastin‐like polypeptides (ELPs) are polypentapeptides that undergo hydrophobic collapse and aggregation above a specific transition temperature, Tt. ELP diblocks sharing a common “core” block (I60) but varying “outer” blocks (A80, P40) were designed, where Tt,I < Tt,A < Tt,P. The formation of ∼55 nm diameter mixed micelles from these ELP diblocks was verified using dynamic light scattering (DLS), multiangle light scattering (MALS) and fluorescence resonance energy transfer (FRET). To confer affinity to the blood circulating protein fibrinogen, a fibrinogen‐binding tetrapeptide sequence (GPRP) was fused to A80‐I60, while P40‐I60 was fused to a non‐binding control (GPSP). The self‐assembling, peptide‐displaying, mixed micelles exhibit temperature‐modulated avidities for immobilized and soluble fibrinogen at 32 °C and 42 °C. In this initial proof‐of‐concept design, the engineered mixed micelles were shown to disengage fibrinogen at elevated temperatures. The modular nature of this system can be used for developing in vivo depot systems that will only be triggered to release in situ upon specific stimuli. Protein‐based mixed micelles with variable avidities to fibrinogen at different temperature regimes are reported. Such a system has potential drug delivery applications as a blood circulating depot that will only be released in situ upon a specific trigger such as temperature (in the current design), pH or oxidative stress.
ISSN:2192-2640
2192-2659
DOI:10.1002/adhm.201200330